trending Market Intelligence /marketintelligence/en/news-insights/trending/vYyTD2IAU-oaCvJi2K-H1A2 content esgSubNav
In This List

Neuren Pharmaceuticals director to retire

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Neuren Pharmaceuticals director to retire

Neuren Pharmaceuticals Ltd said Bruce Hancox will retire as a nonexecutive director on Dec. 31.

Hancox had served in the role for nearly six years.